Synthetically lethal interactions involving loss of the yeast ERG24: the sterol C-14 reductase gene.

Biology Department, Indiana University-Purdue University Indianapolis, 723 West Michigan Street, Indianapolis, IN 46202, USA.
Lipids (Impact Factor: 2.35). 03/2007; 42(1):69-76. DOI: 10.1007/s11745-006-1001-4
Source: PubMed

ABSTRACT ERG2 and ERG24 are yeast sterol biosynthetic genes which are targets of morpholine antifungal compounds. ERG2 and ERG24 encode the C-8 sterol isomerase and the C-14 reductase, respectively. ERG2 is regarded as a non-essential gene but the viability of ERG24 depends on genetic background, type of medium, and CaCl(2) concentration. We demonstrate that erg2 and erg24 mutants are viable in the deletion consortium background but are lethal when combined in the same haploid strain. The erg2erg24 double mutant can be suppressed by mutations in the sphingolipid gene ELO3 but not ELO2. Suppression occurs on rich medium but not on synthetic complete medium. We also demonstrate that the suppressed elo3erg2erg24 does not have a sterol composition markedly different from that of erg24. Further genetic analysis indicates that erg24 combined with mutations in erg6 or erg28 is synthetically lethal but when combined with mutations in erg3 is weakly viable. These results suggest that novel sterol intermediates probably contribute to the synthetic lethality observed in this investigation.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Fusarium graminearum, the causal agent of wheat head blight, shows intrinsic resistance to amine fungicides. It is commonly accepted that the amines target sterol C-14 reductase and sterol Δ(8)-Δ(7) isomerase of ergosterol biosynthesis, encoded by the genes ERG24 and ERG2, respectively. Analysis of the genome sequence of F. graminearum revealed that the fungus contains two paralogous FgERG24 genes (FgERG24A and FgERG24B), which are homologous to the ERG24 of Saccharomyces cerevisiae. In this study, we disrupted FgERG24A and FgERG24B in F. graminearum. Compared to the wild-type strain HN9-1, FgERG24A and FgERG24B deletion mutants did not show recognizable phenotypic changes in mycelial growth on potato dextrose agar or in virulence on wheat heads. HPLC analysis showed that the amount of ergosterol in FgERG24A or FgERG24B deletion mutants was not significantly different from that in the wild-type strain. These results indicate that neither of the two genes is essential for growth, pathogenicity or ergosterol biosynthesis in F. graminearum. FgERG24B deletion mutants exhibited significantly increased sensitivity to amine fungicides, including tridemorph, fenpropidin and spiroxamine, but not to non-amine fungicides. In contrast, FgERG24A deletion mutants did not show changed sensitivity to any amine tested. The resistance of the FgERG24B deletion mutant to amines was restored by genetic complementation of the mutant with wild-type FgERG24B. These results indicate that FgERG24B controls the intrinsic resistance of F. graminearum to amines. The finding of this study provides new insights into amine resistance in filamentous fungi.
    Microbiology 03/2011; 157(Pt 6):1665-75. DOI:10.1099/mic.0.045690-0 · 2.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Antifungal resistance at the gene level has been studied in Candida albicans for about a decade now. Cloning of C. albicans genes by homology to resistance genes in Saccharomyces cerevisiae, heterologous expression of C. albicans genes in S. cerevisiae, regulated expression in C. albicans, and microarray- based expression analysis, have allowed rapid progress in identifying and studying the fi ve major C. albicans genes involved in resistance to clinically used antifungals: ABC transporter genes CDR1 and CDR2, major facilitator effl ux gene MDR1, and ergosterol biosynthesis genes ERG11 and ERG3. Analysis of these genes indicates that resistance involves alterations to the enzyme targeted by fl uconazole (FLZ), encoded by ERG11, and upregulation of P-glycoprotein type ABC transporters and major facilitators (MFs) that effl ux azoles and terbinafi ne. Potential alterations to ERG3 or its regulation have been understudied in C. albicans. Resistant isolates from clinical samples, especially in oropharyngeal candidiasis (OPC), typically display stepwise mutations in more than one of these genes. Key mutations hyperactivate transcriptional activators of CDR1 or MDR1. However, it is clear from in vivo and in vitro studies that mutations of these major genes do not completely account for the evolution of high-level azole resistance in some clinical isolates. More work is needed to identify other genes that contribute to resistance in C. albicans. Very little is understood about reversible, adaptive resistance of C. albicans, despite its potential clinical signifi - cance. Most clinical failures to control non-OPC infections occur with in vitro susceptible strains. There has been important discovery of tolerance mechanisms to azoles. Heterologous studies in S. cerevisiae on regulation of target genes have been less useful because of differences in regulation in C. albicans. Nevertheless, recent progress has been made in identifying genes that regulate CDR1, MDR1, and ERG genes.
    12/2008: pages 347-407;
  • [Show abstract] [Hide abstract]
    ABSTRACT: In yeast, deletion of ERG27, which encodes the sterol biosynthetic enzyme, 3-keto-reductase, results in a concomitant loss of the upstream enzyme, Erg7p, an oxidosqualene cyclase (OSC). However, this phenomenon occurs only in fungi, as mammalian Erg27p orthologues are unable to rescue yeast Erg7p activity. In this study, an erg27 mutant containing the mouse ERG27 orthologue was isolated that was capable of growing without sterol supplementation (FGerg27). GC/MS analysis of this strain showed an accumulation of squalene epoxides, 3-ketosterones, and ergosterol. This strain which was crossed to a wildtype and daughter segregants showed an accumulation of squalene epoxides as well as ergosterol indicating that the mutation entailed a leaky block at ERG7. Upon sequencing the yeast ERG7 gene an A598S alteration was found in a conserved alpha helical region. We theorize that this mutation stabilizes Erg7p in a conformation that mimics Erg27p binding. This mutation, while decreasing OSC activity still retains sufficient residual OSC activity such that the strain can function in the presence of the mammalian 3-keto reductase enzyme and no longer requires the yeast Erg27p. Because sterol biosynthesis occurs in the ER, a fusion protein was synthesized combining Erg7p and Erg28p, a resident ER protein and scaffold of the C-4 demethyation complex. Both FGerg27 and erg27 strains containing this fusion plasmid and the mouse ERG27 orthologue showed restoration of ergosterol biosynthesis with minimal accumulation of squalene epoxides. These results indicate retention of Erg7p in the ER increases its activity and suggest a novel method of regulation of ergosterol biosynthesis.
    Biochimica et Biophysica Acta 09/2012; DOI:10.1016/j.bbalip.2012.09.012 · 4.66 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014